• Bookmark and Share

ABOUT PREECLAMPSIA

Last Updated on Monday, July 05, 2010

Preeclampsia is a disorder that occurs only during pregnancy and the postpartum period and affects both the mother and the unborn baby. Affecting at least 5-8% of all pregnancies, it is a rapidly progressive condition characterized by high blood pressure and the presence of protein in the urine. Swelling, sudden weight gain, headaches and changes in vision are important symptoms; however, some women with rapidly advancing disease report few symptoms.

Typically, preeclampsia occurs after 20 weeks gestation (in the late 2nd or 3rd trimesters or middle to late pregnancy) and up to six weeks postpartum (after delivery), though in rare cases it can occur earlier than 20 weeks. Proper prenatal care is essential to diagnose and manage preeclampsia. Pregnancy Induced Hypertension (PIH) and toxemia are outdated terms for preeclampsia. HELLP syndrome and eclampsia (seizures) are other variants of preeclampsia. 

Globally, preeclampsia and other hypertensive disorders of pregnancy are a leading cause of maternal and infant illness and death. By conservative estimates, these disorders are responsible for 76,000 maternal and 500,000 infant deaths each year.

UPCOMING EVENTS

We’ll be Speaking Here

Northside Hospital CME, Atlanta, GA

August 21, 2015 

7th Annual Perinatal Safety Summit, Las Vegas, NV

October 1-2, 2015

Invite Us to Speak at Your Event

 

Preeclampsia in the News

Featured Video

What’s Happening on Twitter

Preeclampsia Our very first Vision Grant recipient, Dr. Garrett Lam, is featured in The Chattanoogan along with the story of... http://t.co/AcwFNVGQAe
Preeclampsia Good news for lupus patients! Newly published results of a 10-year study on lupus patients has found that women... http://t.co/Ptzof7ARW0
Preeclampsia We are only $27,000 away from goal but we need YOU! Although that does not seem like much, it means the... http://t.co/TKtFAj9iZN

Press Releases by Year

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.